Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1

We describe the use of iterative in situ Click Chemistry to design an Akt-specific branched peptide triligand that is a drop-in replacement for monoclonal Antibodies in multiple biochemical assays. Each peptide module in the branched structure makes unique contributions to affinity and/or specificity resulting in a 200 nM affinity ligand that efficiently immunoprecipitates Akt from Cancer cell lysates and labels Akt in fixed cells. Our use of a small molecule to preinhibit Akt prior to screening resulted in low micromolar inhibitory potency and an allosteric mode of inhibition, which is evidenced through a series of competitive Enzyme kinetic assays. To demonstrate the efficiency and selectivity of the protein-templated in situ click reaction, we developed a novel QPCR-based methodology that enabled a quantitative assessment of its yield. These results point to the potential for iterative in situ Click Chemistry to generate potent, synthetically accessible antibody replacements with novel inhibitory properties.